Simultaneous Voltage and Calcium Mapping of Genetically Purified Human Induced Pluripotent Stem Cell–Derived Cardiac Myocyte Monolayers
This article has a companion.
VIEW THE COMPANIONAbstract
Rationale:
Human induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) offer a powerful in vitro tool to investigate disease mechanisms and to perform patient-specific drug screening. To date, electrophysiological analysis of iPSC-CMs has been limited to single-cell recordings or low-resolution microelectrode array mapping of small cardiomyocyte aggregates. New methods of generating and optically mapping impulse propagation of large human iPSC-CM cardiac monolayers are needed.
Objective:
Our first aim was to develop an imaging platform with versatility for multiparameter electrophysiological mapping of cardiac preparations, including human iPSC-CM monolayers. Our second aim was to create large electrically coupled human iPSC-CM monolayers for simultaneous action potential and calcium wave propagation measurements.
Methods and Results:
A fluorescence imaging platform based on electronically controlled light-emitting diode illumination, a multiband emission filter, and single camera sensor was developed and utilized to monitor simultaneously action potential and intracellular calcium wave propagation in cardiac preparations. Multiple, large-diameter (≥1 cm), electrically coupled human cardiac monolayers were then generated that propagated action potentials and calcium waves at velocities similar to those commonly observed in rodent cardiac monolayers.
Conclusions:
The multiparametric imaging system presented here offers a scalable enabling technology to measure simultaneously action potential and intracellular calcium wave amplitude and dynamics of cardiac monolayers. The advent of large-scale production of human iPSC-CMs makes it possible to now generate sufficient numbers of uniform cardiac monolayers that can be utilized for the study of arrhythmia mechanisms and offers advantages over commonly used rodent models.
Introduction
The advent of induced pluripotent stem cell (iPSC) technology has increased the impetus to improve bioengineering and imaging methodologies to enable the mechanistic study of human cardiac preparations manifesting disease phenotypes and for drug testing in vitro.1,2 However, the laborious nature of single-cell electrophysiological recordings commonly used as an electrophysiological assay precludes efficient screening of electric wave propagation through a functional syncytium of cardiac tissue.2 Microelectrode arrays and optical mapping have been used on small iPS cell-derived cardiomyocyte (iPSC-CM) aggregates, but observed conduction velocities have been very low (<2.5 cm s−1).3,4
In This Issue, see p 1539
A new method is needed to enable the generation of large electrically coupled human iPSC-CM monolayers that propagate action potentials and calcium waves with much higher speeds. Using genetically selected and purified iPSC-CMs, we report here a new method for the generation of electrically coupled human cardiac monolayers (≥1 cm diameter) that uniformly conduct action potentials and calcium waves at velocities comparable with those commonly observed in neonatal rat ventricular myocyte monolayers (>20 cm s−1). This new cell and bioengineering technology enables future studies of arrhythmia mechanisms and drug screening using patient-specific cardiac monolayers rather than just rodent model systems.
Methods
Reference Applications of the Imaging Platform for Simultaneous Voltage and Ratiometric Calcium Mapping in Cardiac Tissue
Detailed Methods are provided in the Online Supplement. Here, we use a novel optical mapping system for simultaneous Vm and ratiometric intracellular calcium ([Ca2+]i) imaging of cardiac preparations, including human iPSC-CM monolayers. The optical mapping system presented here (Figure 1) offers several advantages over most existing systems for multiparametric imaging. First is the use of multiple light-emitting-diodes (LEDs) as excitation light sources, which provide a stable, flexible, and economical alternative to established methods. Unlike traditional light sources, LED light intensity can be modulated with exceedingly fast response times, thus making high-speed excitation light switching possible without the need for moving parts. Based on recent advances in LED fabrication technology, powerful LEDs are now available that cover the entire spectrum from deep ultraviolet to infrared, making them an increasingly attractive alternative for multiparametric cardiac imaging.5 Second, the imaging method presented here provides a means for quantitative (ratiometric) calcium wave imaging in cardiac tissue of various levels of structural complexity. The use of fluorescence for quantitative measurement is difficult because fluorescence intensity is affected by a range of ill-controlled factors, such as regional differences in dye loading, internalization in subcellular compartments, and photo-bleaching. These limitations are particularly relevant when utilizing single-excitation/single-emission fluorescent dyes. To address this, ratiometric Ca2+ dyes are utilized that, on binding Ca2+, display spectral shifts with opposite polarity on exposure to different excitation wavelengths.6 The ratio of the two emission intensities is independent of fluorescence signal intensity, thereby providing a means of quantifying [Ca2+]i and allowing reliable comparison between regions and samples.6 Third, we have utilized a low-affinity ratiometric Ca2+ dye, fura-4F. To minimize perturbation of the [Ca2+]i dynamics in cardiac tissue, the choice of Ca2+ dye is critical for acquiring accurate measurements of the amplitude and time course of [Ca2+]i transients. For cardiac myocytes and tissue, which show large and rapid changes in [Ca2+]i, a low-affinity and rapidly responding dye is needed.7 Other commonly used ratiometric Ca2+ dyes, such as fura-2, have a relatively high-affinity for Ca2+. This can lead to an artificial prolongation of the Ca2+ transient and confound interpretation (ie, the dye acts as a chelator that releases Ca2+ with delay). Fourth, the new system uses a single sensor with a multiband transmission filter and no moving parts. The use of a single sensor obviates the technical complexity of multisensor alignment for simultaneous multiparametric imaging.8 More complete details of the optical mapping set-up and electronics are available in the Online Supplement.
We have thoroughly validated the performance of this optical mapping system using cardiac tissue of various levels of structural complexity from monolayers of cardiac myocytes to native cardiac tissue slices and the whole heart (Figures 2, 3). Details about each cardiac preparation can be found in the Online Supplement. Figure 2A demonstrates the utility of the system for studying cardiac arrhythmia mechanisms in neonatal rat ventricular myocyte monolayers, a commonly used in vitro model.9 Using our mapping system, we were able to monitor simultaneously Vm and [Ca2+]i wave propagation of electric rotors (re-entrant electric activity that can underlie cardiac arrhythmias; Online Movie I). Comparison of the data, also illustrated in the 2 snapshots presented in Figure 2A, reveals that the rotating Vm wavefront precedes the Ca2+ wavefront by approximately 10 ms. Next, we demonstrate simultaneous Vm and [Ca2+]i imaging of thin (≤350-μm-thick) ventricular tissue slices (Figure 2B; Online Movie II). Cardiac tissue slices represent an exciting pseudo-two-dimensional model that balances structural complexity (cells within the slice are in an environment that is as close to native as possible in vitro) and ease of data interpretation (observed signals can be related more reliably to their histological sources).10,11 As illustrated in Figure 2C, we also used the same imaging system to map Vm and [Ca2+]i wave propagation in Langendorff-perfused rat hearts (Online Movie III). Normalized fluorescence intensity maps for Vm and [Ca2+] were recorded during sinus rhythm and are shown at two time points 9.72 ms apart. The entire anterior epicardial surface of the ventricles activated almost simultaneously, whereas the peak of [Ca2+]i occurred with a delay of approximately 16 ms.
Generation of Human iPSC-CM Monolayers
Next, we generated human cardiac monolayers to enable the simultaneous mapping of Vm and [Ca2+]i wave propagation in a human model system. Human iPSC-CMs were obtained from Cellular Dynamics International (Madison, WI). The iCell cardiomyocytes are highly purified human cardiac myocytes (>98% pure cardiomyocytes) derived from iPS cells using cardiac-directed differentiation and purification protocols.12 Importantly, the high purity of these cardiomyocyte cultures remains unchanged over the course of at least 2 weeks in culture. The iCell cardiomyocytes are differentiated from human iPS cells reprogrammed from a nonembryonic terminally differentiated cell source, thus avoiding the ethical controversy surrounding embryonic stem cell use. Cryopreserved vials (liquid nitrogen) of iCell human cardiac myocytes were thawed and subsequently plated on bovine fibronectin-coated (20 μg/mL; Invitrogen) transparent silastic membranes at a density of 125,000 cells per monolayer in differentiation media13 (embryoid body differentiation media, commonly referred to as embryoid body-20, comprising 80% Dulbecco Modified Eagle Medium [DMEM/F12], 0.1 mmol/L−1 nonessential amino acids, 1 mmol/L−1 L-glutamine, 0.1 mmol/L−1 β-mercaptoethanol, and 20% fetal bovine serum; Gibco) supplemented with 10 μmol/L−1 blebbistatin. After 24 hours in embryoid body-20,13 the medium was switched to iCellmaintenance medium, supplemented with 10 μmol/L−1 blebbistatin, and cells were cultured for an additional 96 hours at 37°C, in 5% CO2, with the medium changed once daily. Monolayers (n=4) were subsequently processed for electrophysiological analysis by optical mapping as described for neonatal rat cardiomyocyte monolayers or for immunocytochemistry analysis (n=7). The cellular structure and composition of typical monolayers generated in this study are presented in Figures 3 and 4.
Results
Human iPSC-CM and Monolayer Structure
Cardiomyocytes were plated on fibronectin-coated transparent silastic membranes as described. Immunostaining was performed essentially as described recently.12 For immunostaining, cells were washed with phosphate-buffered saline, fixed with 4% paraformaldehyde for 10 minutes, and rinsed twice before blocking with 5% donkey serum in phosphate-buffered saline plus 0.1% Triton X-100 (Sigma) for 1.5 hours at room temperature. Primary antibodies including mouse monoclonal anti-MLC-2a (IgG2b, 1:200 dilution; Synaptic Systems), rabbit polyclonal anti-MLC-2v (IgG, 1:100 dilution; ProteinTech Group), mouse monoclonal α-actinin (1:500; Sigma), and rabbit polyclonal connexin 43 (1:100; Millipore) were added to 5% donkey serum in phosphate-buffered saline plus 0.1% Triton X-100 and incubated overnight at 4°C with constant agitation. Subsequently, samples were washed three times in phosphate-buffered saline plus 0.1% Triton X-100. The secondary antibodies donkey antirabbit DyLight 488 and donkey antimouse DyLight 594 (1:500 dilution; Jackson ImmunoResearch) were diluted in the same solution as primary antibodies and incubated at room temperature in the dark for 1.5 hours. Negative control experiments using only the secondary antibodies were performed to ensure specificity of immunostaining and fluorescence detection. Samples were then washed three times with phosphate-buffered saline plus 0.1% Triton X-100 and once with phosphate-buffered saline only. Finally, nuclei were stained with DAPI (1:1000 dilution; Invitrogen) for 10 minutes at room temperature in the dark. Cover slips were mounted on microscope slides for confocal imaging.
Immunofluorescence imaging was performed using a 20× or 60× objective on a Nikon A1R laser scanning confocal microscope system (Nikon Instruments, Melville, NY). Figure 3 shows the cellular and subcellular structure of representative cardiac monolayers that were used in this study. Figure 3A shows a cardiomyocyte monolayer immunostained for α-actinin (red) and nuclei (DAPI, blue). Consistent with a recent report using iCell cardiomyocytes,12 nuclei were evenly distributed and α-actinin positive staining was present throughout the field of view. Higher magnification (60×) image in Figure 3B shows the sarcomere structure of the Z-line protein α-actinin (red) and also shows that the gap junction protein connexin 43 (green) is localized at the points of myocyte–myocyte contact. This suggests that impulse propagation in these human monolayers may be mediated through cell-to-cell communication via connexin 43. Figures 3C to 3E show the result of coimmunolabeling for α-actinin (sarcomeric Z-line) and MLC-2v (sarcomeric A-band). Figure 3C demonstrates that not all myofilaments stained positive for the ventricular-specific myosin light chain (MLC-2v). For MLC-2v–positive myofilaments, alternating Z-line and A-band staining was observed (Figure 3D). A fluorescence intensity plot over the distance denoted by the white arrow in Figure 3D is shown in Figure 3E. Proper spatial organization of the sarcomeric Z-line (red) and A-band (green, MLC-2v staining is localized in each half of the sarcomeric A-band) suggests a degree of functional maturity of the cardiac sarcomere.14 The average sarcomere length, measured by multiple single measures of the Z-line to Z-line distance, is 1.98±0.03 μm (n=51 myocytes) for myocytes in these monolayers (Figure 3E).
Flow Cytometry Analysis of Cardiac Myocyte Population
Next, we used immunofluorescence and flow cytometry to quantify the cardiomyocyte population in iCell cardiomyocyte monolayers. Expression of the two cardiac MLC-2 isoforms of the heart, MLC-2a and MLC-2v, provides information about the diversity of the cardiomyocyte population. The MLC-2a expression is detected in all chambers of developing mouse and human hearts. Postnatally, MLC-2a expression is restricted to the atria in mice, whereas MLC-2a expression is found in both the atria and, to a lesser extent in the ventricles in humans.15,16 However, MLC-2v expression is restricted to the ventricular chambers in humans, and this chamber specificity persists into adulthood.15,16 In mouse and human embryoid bodies, MLC-2a expression precedes MLC-2v expression, thereby suggesting that MLC-2v expression is also a marker of myocyte maturity.14,15 Immunofluorescence and laser confocal scanning analysis demonstrate that these monolayers are comprised of at least three phenotypes expressing primarily MLC-2a (red), MLC-2v (green), and both MLC-2a and MLC-2v (yellow in Figure 4A, B). Cells expressing MLC-2v likely represent ventricular-like cells, whereas MLC-2a–only expressing cells can identify a range of potential cardiomyocyte types, including atrial-like cells.
Results of flow cytometry analysis using MLC-2a–specific and MLC-2v–specific antibodies are shown in Figures 4C and 4D. For flow cytometry, cells were washed with phosphate-buffered saline and then incubated with 1 mL/well of 0.25% Trypsin-EDTA plus 2% chicken serum for 5 minutes. Equal volume of embryoid body-20 medium, containing 20% fetal bovine serum, was subsequently used to inhibit trypsinization. Cells were detached from the cover slips and aggregates were disrupted to singularize the cells by pipetting up and down. Cell suspensions were centrifuged for 5 minutes at 1,000 rpm; the supernatant was discarded and cell pellets were resuspended in 1 mL 1% paraformaldehyde and incubated at 37°C for 10 minutes to fix the cells. Samples were centrifuged and pellets were resuspended in 1 mL ice-cold methanol before incubation on ice for 30 minutes to permeabilize the cells. Cells were washed once with FACS buffer (phosphate-buffered saline without Ca2+/Mg2+, 1% bovine serum albumin) plus 0.1% Triton and centrifuged, and the supernatant was discarded, leaving a volume of 100 μL. Primary antibodies for MLC-2a (Synaptic Systems, mouse monoclonal, dilution 1:200) and MLC-2v (ProteinTech Group, rabbit polyclonal, dilution 1:400) were dissolved in 100 μL/sample FACS buffer plus 0.1% Triton for total sample volume of 200 μL. Samples were incubated with primary antibodies overnight at 4°C. Cells were washed twice in 3 mL FACS buffer plus 0.1% Triton and centrifuged, and supernatant was discarded, leaving approximately 100 μL. Secondary antibodies (donkey antimouse Dylight 488 and donkey antirabbit Dylight 594, dilution 1:500; Jackson ImmunoResearch) were dissolved in 100 μL/sample FACS buffer plus 0.1% Triton for total sample volume of 200 μL and incubated for 45 minutes in the dark at room temperature. Cells were washed twice in FACS buffer plus 0.1% Triton, centrifuged, resuspended in 200 μL FACS buffer plus 0.1% Triton, and stored on ice until FACS analysis. To define the thresholds for positive 488 and 594 fluorescence, negative control samples were incubated with 488 or 594 secondary antibodies only. Black peaks in Online Figure I represent both the background fluorescence of the secondary antibodies and the autofluorescence of the cells. Green and red peaks show, respectively, 488 and 594 fluorescence for positive control samples (Online Figure I). Both negative and positive control samples allow gating precisely for 488 and 594 positive fluorescence thresholds. Data were collected on a FACS system (MoFlo XDP) and analyzed using FlowJo version 9.4.11. Flow cytometry confirms the immunofluorescence staining of MLC-2a and MLC-2v as shown in Figures 4C and 4D. Three distinct populations of CMs were identified: MLC-2a+/MLC-2v− (upper left quadrant, 8.4%); MLC-2a+/MLC-2v+ (upper right quadrant, 13.6%); and MLC2a-/MLC2v+ (lower right quadrant, 44.6%). This is similar to the subpopulations of atrial and ventricular myocytes identified using electrophysiology criteria of action potential (AP) morphology of iCell cardiomyocytes.12
Simultaneous Voltage and Calcium Mapping in Human iPSC-CM Monolayers
We generated large (approximately 1-cm diameter) human iPSC-CM monolayers for optical mapping using genetically selected iPSC-CMs (iCell; Cellular Dynamics International). These iPSC-CM monolayers exhibit spontaneous pacemaker activity (1.22±0.09 Hz; n=4; Figure 5A and Online Movie IV), and they also can be electrically stimulated (Figure 5A and Online Movie V). Uniform propagation of Vm and [Ca2+]i through the entire monolayer was observed in each case (n=4), as shown in the representative activation maps of Figure 6 (conduction velocity=21.9±2.47 cm/s−1 and a Vm to [Ca2+]i peak delay of approximately 33 ms). The Vm activation maps of spontaneous pacemaker activity recorded in two separate monolayers are shown in Figures 6A and 6C. Figures 6B and 6D show activation maps of paced beats in where the stimulator was placed approximately at the center of the monolayer, and where the Vm wave spread uniformly through the monolayer in all directions.
Figure 7 shows the uniformity of AP and [Ca]i characteristics across the monolayer. The action potential duration (APD) at 90% repolarization (APD90) and the [Ca]i transient duration at 90% return to baseline (CaT90) are shown from four spatially distinct locations during spontaneous and electrically paced propagation (indicated by blue, red, green, and cyan squared regions). The right panel of Figure 7A presents APD90 and CaT90 during spontaneous activity (cycle length of 1,267±12 ms), the left panel of Figure 7B presents APD90 and CaT90 during electrically paced activity (cycle length of 500 ms), and the right panel of Figure 7B presents APD90 and CaT90 during electrically paced activity (cycle length of 750 ms). As can be seen, the transient duration characteristics for each parameter are uniform across the plate and increase with cycle length. Three consecutive transients, after equilibration, were taken for each data point. The same analysis for another representative monolayer can be found in Online Figure II.
Discussion
Novel bioengineering techniques are continuously being developed to create human cardiac tissue constructs that can be used to improve cardiac research and for development of cardiac regeneration therapies.17 The novel imaging and bioengineering approaches presented here offer the potential to increase throughput quantification of action potential and Ca2+ wave propagation in iPSC-CM multicellular tissue constructs. We generated large electrically coupled human iPSC-CM monolayers for optical mapping using genetically selected iPSC-CMs (iCell; Cellular Dynamics International; Figure 3). Although previous studies have explored Vm and [Ca2+]i (nonratiometrically) by imaging, each parameter individually (using a different set of voltage and calcium dyes in small [diameter ≤1 mm] human iPSC-CM monolayers),3 simultaneous Vm, and ratiometric [Ca2+]i imaging have not yet been reported to our knowledge.
To date, action potential conduction velocity of iPSC-CM aggregates measured using multiple electrode array technology has been very slow (1–2.5 cm/s−1).4 Similarly, higher spatial resolution optical mapping of small iPSC-CM aggregates (approximately 400 μm diameter) have shown very slow (1–2 cm/s−1) action potential spread.3 These conduction velocities pale in comparison to the more commonly used neonatal rat ventricular myocyte monolayer model in which conduction velocities are typically an order of magnitude faster, approximately20 to 25 cm/s−1. Using genetically selected iPSC-CM and the monolayer formation method described here, we generated human cardiac monolayers that conducted electric waves at velocities comparable with neonatal rat cell cultures, approximately 21 cm/s−1. The fast conduction velocities reported here may be attributable to the use of genetically purified human cardiac myocytes (approximately 98% purity) or to the use of flexible silastic membranes as opposed to rigid plastic Petri dishes or multielectrode dishes. Regardless of the mechanism, these human iPSC-CM monolayers provide an attractive alternative to rodent monolayer models for in vitro testing of potential drug therapies, and for the study of arrhythmia mechanisms.
Human iPSC-derived cardiac myocytes are emerging as a technology for the development of in vitro patient-specific disease models for drug testing and for the development of regenerative therapies. Genetically linked cardiomyopathies such as long QT syndrome,1,18 Timothy syndrome,19 LEOPARD syndrome,20 and catecholaminergic polymorphic ventricular tachycardia21 have been studied recently using patient-specific iPSC-derived cardiac myocytes. In each of these reports, the patient-specific cardiomyocytes recapitulated the electrophysiological phenotype of the specific disease. For example, myocytes obtained from long QT syndrome patients exhibit APD prolongation, development of early depolarization, and triggering of spontaneous beats. Indeed, human iPSC-CMs have ionic currents and channel gating properties underlying their APs and after depolarizations that are quantitatively similar to those reported for human cardiac myocytes.12 The iCell cardiomyocytes have more negative maximum diastolic potential values for atrial-like and ventricular-like APs compared with reports with human embryonic stem cell-derived cardiomyocytes, and the AP durations are within the normal range of the human ECG QT interval.12 Ma et al12 reported that the maximum diastolic potential of ventricular-like iCell CMs is −76 mV, and the maximum diastolic potential of atrial-like CM is −73 mV. This is hyperpolarized compared with the average resting membrane potential of rodent monolayer systems, which is −65 mV. The AP amplitude of iCell CMs was similar for atrial and ventricular cells (100 mV and 104 mV, respectively) in that study, as was the dV/dt max (26 V/s and 28 V/s). The APDs reported by Ma et al differed between atrial and ventricular CMs (286 ms versus 414 ms, respectively). Thus, the electrophysiological characteristics of the cardiomyocytes used here have some properties of more mature human cardiac myocytes and offer advantages over commonly used rodent model systems. Here, we present, using optical mapping, that the APD90 of human iPSC-CM monolayers is approximately 340 ms (Figure 7), which is in between the APD of human iPSC ventricular and atrial myocytes.12 This APD is anticipated in an electrotonically interconnected mix of the two electrophysiologically distinct CM types. Furthermore, the APD90 of human iPSC monolayers recorded here is two-times longer than the APD90 of neonatal rat ventricular myocyte monolayers (approximately 170 ms at 1-Hz pacing).9 The spontaneous beating rate of human iPSC-CM monolayers observed here (1.2 Hz) is representative of the resting adult human heart rate (60–70 bpm). However, the spontaneous beating rate of neonatal rat ventricular myocyte monolayers varies widely, typically between 1 and 4 Hz,22 which is much slower than the heart rate of adult rats. Therefore, besides the human source of iPSC-CMs being an advantage over using rodent systems, the electrophysiological phenotype of these human myocytes offer a model system that cannot be recapitulated using rodent systems.
As pointed out recently,23 the transition from “bench to bedside” and realization of the full potential of human iPSC-CM technology will require more time and work to overcome other limitations of the technology, including the heterogeneity of the cell types (Figure 4). Nevertheless, the use of human iPSC-CM monolayer systems as presented here offers a novel model for the mechanistic study of human cardiac impulse generation and propagation for the mechanisms involved in arrhythmogenesis. Furthermore, the use of patient-specific iPSC-CMs and monolayers offers a potentially unique ex vivo approach to obtaining clinically relevant information.
Novelty and Significance
This article has a companion.
VIEW THE COMPANION•
Human-induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) represent a new model for personalized study of heart disease.
•
Transmembrane voltage, intracellular calcium homeostasis, and impulse propagation are three key parameters of interest in the study of heart disease and drug effects; however, a simple and scalable imaging platform for simultaneously measurement all three parameters in macroscopic human iPSC-CM tissue constructs is needed.
•
Large electrically coupled human cardiac monolayers can be produced using genetically purified human iPSC-CMs, permitting the study of the mechanisms of arrhythmia in human cells.
•
The results demonstrate the potential of the system for simultaneous mapping of the three key parameters, transmembrane voltage, intracellular calcium concentration, and excitation propagation, for studying cardiac physiology and pathology and for high-throughput drug testing.
Human iPSC-CMs can be used to study human disease mechanisms to investigate genetic disorders and to perform patient-specific drug testing. To date, most studies using human iPSC-CMs have measured cellular phenotypes, and there is a paucity of experimentation reported at the multicellular level. To take advantage of this powerful tool, large electrically coupled tissue constructs must be developed and new scalable multiparametric imaging platforms are needed. This study describes the production of large electrically coupled monolayers using genetically purified human iPSC-CMs and an imaging platform capable of simultaneously measuring action potential and intracellular calcium wave propagation. Human cardiac monolayers were formed on elastic membranes using readily accessible commercial iPSC-CMs and the imaging platform was constructed using a single camera and off-the-shelf light-emitting-diodes, multiband optical filters, and electronics. These human cardiac monolayers yielded impulse conduction velocities significantly higher than previously reported, highlighting the importance of the mechanical environment and cell purity. The use of human iPSC-CM cardiac monolayers offers several advantages over commonly used rodent monolayer systems for the study of disease and arrhythmia mechanisms. This approach could be scaled-up for high-throughput investigations into the mechanisms of human arrhythmias or for studying patient-specific drug effects.
Footnote
Non-standard Abbreviations and Acronyms
- iPSC
- induced pluripotent stem cells
- iPSC-CM
- induced pluripotent stem cell–derived cardiomyocyte
- LED
- light-emitting diode
- Vm
- membrane voltage
Supplemental Material
Sources of Funding
Clarendon Fund Scholarship (P.L.), British Heart Foundation (C.B., P.K.), National Institutes of Health grants P01-HL039707 and P01-HL087226 (J.J.), and the Leducq Foundation (J.J.) all contributed to this work.
References
1.
Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011;471:225–229.
2.
Tiscornia G, Monserrat N, Izpisua Belmonte JC. Modelling long QT syndrome with ips cells: Be still, my beating heart. Circ Res. 2011;108:648–649.
3.
Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 2011;6:e18293.
4.
Mehta A, Chung YY, Ng A, Iskandar F, Atan S, Wei H, Dusting G, Sun W, Wong P, Shim W. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells. Cardiovasc Res. 2011;91:577–586.
5.
Entcheva E, Kostov Y, Tchernev E, Tung L. Fluorescence imaging of electrical activity in cardiac cells using an all-solid-state system. IEEE Trans Biomed Eng. 2004;51:333–341.
6.
Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–3450.
7.
Hollingworth S, Gee KR, Baylor SM. Low-affinity Ca2+ indicators compared in measurements of skeletal muscle Ca2+ transients. Biophys J. 2009;97:1864–1872.
8.
Lee P, Bollensdorff C, Quinn TA, Wuskell JP, Loew LM, Kohl P. Single-sensor system for spatially-resolved, continuous and multi-parametric optical mapping of cardiac tissue. Heart Rhythm. 2011;7:1482–1491.
9.
Hou L, Deo M, Furspan P, Pandit SV, Mironov S, Auerbach DS, Gong Q, Zhou Z, Berenfeld O, Jalife J. A major role for HERG in determining frequency of reentry in neonatal rat ventricular myocyte monolayer. Circ Res. 2010;107:1503–1511.
10.
Pertsov AM, Davidenko JM, Salomonsz R, Baxter WT, Jalife J. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res. 1993;72:631–650.
11.
de Boer TP, Camelliti P, Ravens U, Kohl P. Myocardial tissue slices: Organotypic pseudo-2D models for cardiac research & development. Future Cardiol. 2009;5:425–430.
12.
Ma J, Guo L, Fiene SJ, Anson BD, Thomson JA, Kamp TJ, Kolaja KL, Swanson BJ, January CT. High purity human-induced pluripotent stem cell-derived cardiomyocytes: Electrophysiological properties of action potentials and ionic currents. Am J Physiol. 2011;301:H2006–H2017.
13.
Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30–e41.
14.
Segev H, Kenyagin-Karsenti D, Fishman B, Gerecht-Nir S, Ziskind A, Amit M, Coleman R, Itskovitz-Eldor J. Molecular analysis of cardiomyocytes derived from human embryonic stem cells. Dev Growth Differ. 2005;47:295–306.
15.
Kubalak SW, Miller-Hance WC, O'Brien TX, Dyson E, Chien KR. Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J Biol Chem. 1994;269:16961–16970.
16.
O'Brien TX, Lee KJ, Chien KR. Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube. Proc Nat Acad Sci. 1993;90:5157–5161.
17.
Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, Hauch KD, Pabon L, Reinecke H, Murry CE. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res. 2011;109:47–59.
18.
Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flügel L, Dorn T, Goedel A, Höhnke C, Hofmann F, Seyfarth M, Sinnecker D, Schömig A, Laugwitz KL. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med. 2010;363:1397–1409.
19.
Yazawa M, Hsueh B, Jia X, Pasca AM, Bernstein JA, Hallmayer J, Dolmetsch RE. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature. 2011;471:230–234.
20.
Carvajal-Vergara X, Sevilla A, D'Souza SL, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature. 2010;465:808–812.
21.
Novak A, Barad L, Zeevi-Levin N, Shick R, Shtreichman R, Lorber A, Itskovitz-Eldor J, Binah O. Cardiomyocytes generated from cpvtd307h patients are arrhythmogenic in response to β-adrenergic stimulation. J Cell Mol Med. 2012;16:468–482.
22.
Sekar RB, Kizana E, Smith RR, Barth AS, Zhang Y, Marbán E, Tung L. Lentiviral vector-mediated expression of GFP or Kir2.1 alters the electrophysiology of neonatal rat ventricular myocytes without inducing cytotoxicity. Am J Physiol. 2007;293:H2757–H2770.
23.
Priori SG. Induced pluripotent stem cell-derived cardiomyocytes and long QT syndrome: Is personalized medicine ready for prime time? Circ Res. 2011;109:822–824.
24.
Herron TJ, Lee P, Jalife J. Optical imaging of voltage and calcium in cardiac cells and tissues. Circ Res. 2012;110:609–623.
Information & Authors
Information
Published In
Copyright
© 2012 American Heart Association, Inc.
Versions
You are viewing the most recent version of this article.
History
Received: 10 December 2011
Revision received: 24 April 2012
Accepted: 27 April 2012
Published online: 8 May 2012
Published in print: 8 June 2012
Keywords
Subjects
Authors
Disclosures
None.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Cardiac arrhythmogenesis: roles of ion channels and their functional modification, Frontiers in Physiology, 15, (2024).https://doi.org/10.3389/fphys.2024.1342761
- iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity, Frontiers in Pharmacology, 15, (2024).https://doi.org/10.3389/fphar.2024.1308217
- Creating cell-specific computational models of stem cell-derived cardiomyocytes using optical experiments, PLOS Computational Biology, 20, 9, (e1011806), (2024).https://doi.org/10.1371/journal.pcbi.1011806
- Noninvasive analysis of contractility during identical maturations revealed two phenotypes in ventricular but not in atrial iPSC-CM, American Journal of Physiology-Heart and Circulatory Physiology, 326, 3, (H599-H611), (2024).https://doi.org/10.1152/ajpheart.00527.2023
- Comparing fabrication techniques for engineered cardiac tissue, Journal of Biomedical Materials Research Part A, 112, 11, (1921-1929), (2024).https://doi.org/10.1002/jbm.a.37737
- Biomimetic Approaches in Cardiac Tissue Engineering: Replicating the Native Heart Microenvironment, Cureus, (2023).https://doi.org/10.7759/cureus.43431
- Optical Mapping of Cardiomyocytes in Monolayer Derived from Induced Pluripotent Stem Cells, Cells, 12, 17, (2168), (2023).https://doi.org/10.3390/cells12172168
- Gene-Edited Human-Induced Pluripotent Stem Cell Lines to Elucidate DAND5 Function throughout Cardiac Differentiation, Cells, 12, 4, (520), (2023).https://doi.org/10.3390/cells12040520
- The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes, Bioengineering, 10, 2, (237), (2023).https://doi.org/10.3390/bioengineering10020237
- A fully-automated low-cost cardiac monolayer optical mapping robot, Frontiers in Cardiovascular Medicine, 10, (2023).https://doi.org/10.3389/fcvm.2023.1096884
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.